Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

NCT01251133 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Infectious Disease by Haemophilus Influenzae Type b

Interventions

BIOLOGICAL: LBVH0101 (Hib vaccine)
BIOLOGICAL: Hiberix™ Vaccine

Sponsor

LG Life Sciences